1 year return (CAGR)
95.09%
Bicara Therapeutics Inc. Common Stock Exchange (NASDAQ, USD)
BCAX
22.67
-0.53 (-2.28%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-
5 year return (CAGR)
-
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
1.50B
Price/Sales
-
Ent value
1.45B
Price/Book
3.20
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 23.11 |
| Daily high | 23.11 |
| Daily low | 22.48 |
| Daily Volume | 706K |
| All-time high | 30.40 |
| 1y analyst estimate | 33.50 |
| Beta | - |
| EPS (TTM) | -2.73 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 26 Mar 2026 |
Downside potential
Loading...
Downside potential data
| BCAX | S&P500 | |
| Current price drop from All-time high | -25.43% | -2.63% |
| Highest price drop | -67.82% | -56.47% |
| Date of highest drop | 27 Jun 2025 | 9 Mar 2009 |
| Avg drop from high | -36.31% | -10.68% |
| Avg time to new high | 72 days | 12 days |
| Max time to new high | 445 days | 1805 days |
News
